Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches
SA Taleb, AA Al Thani, K Al Ansari… - European Journal of …, 2018 - Springer
Respiratory syncytial virus continues to pose a serious threat to the pediatric populations
worldwide. With a genomic makeup of 15,200 nucleotides, the virus encodes for 11 proteins …
worldwide. With a genomic makeup of 15,200 nucleotides, the virus encodes for 11 proteins …
Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review
While significant progress has been made in understanding and applying gene silencing
mechanisms and the treatment of human diseases, there have been still several obstacles in …
mechanisms and the treatment of human diseases, there have been still several obstacles in …
Antiviral activity of polysaccharide extract from Laminaria japonica against respiratory syncytial virus
Y Cao, Y Hao, Z Li, S Liu, L Wang - Biomedicine & Pharmacotherapy, 2016 - Elsevier
This study was designed to investigate the inhibition activity of polysaccharide extract from
Laminaria japonica against RSV. The polysaccharide from Laminaria japonica was isolated …
Laminaria japonica against RSV. The polysaccharide from Laminaria japonica was isolated …
Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases
Emerging therapies based on localized delivery of siRNA to lungs have opened up exciting
possibilities for treatment of different lung diseases. Localized delivery of siRNA to lungs has …
possibilities for treatment of different lung diseases. Localized delivery of siRNA to lungs has …
siRNA-mediated simultaneous regulation of the cellular innate immune response and human respiratory syncytial virus replication
M Martín-Vicente, S Resino, I Martínez - Biomolecules, 2019 - mdpi.com
Human respiratory syncytial virus (HRSV) infection is a common cause of severe lower
respiratory tract diseases such as bronchiolitis and pneumonia. Both virus replication and …
respiratory tract diseases such as bronchiolitis and pneumonia. Both virus replication and …
Short hairpin RNA-mediated matrix gene silencing of human respiratory syncytial virus as a potent antiviral strategy
Aim: Human respiratory syncytial virus (HRSV) is a common cause of respiratory infections,
particularly in infants and the elderly. Ribavirin is the only US FDA-approved antiviral drug …
particularly in infants and the elderly. Ribavirin is the only US FDA-approved antiviral drug …
[PDF][PDF] Design of therapeutic siRNAs for SARS-CoV-2
A Salimi, T Jafarzadeh, SM Mohammadi - academia.edu
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has impressed many people in the world. Despite …
syndrome coronavirus 2 (SARS-CoV-2) has impressed many people in the world. Despite …
[PDF][PDF] Journal of Molecular Virology and Immunology
SA HUDU - Toxicology Research - researchgate.net
Hepatitis viruses (hepatotropic viruses) are classified into five kinds, denoted by the letters A,
B, C, D, and E, each with its own unique genotypes, clinical implications, and geographic …
B, C, D, and E, each with its own unique genotypes, clinical implications, and geographic …
[PDF][PDF] Lucas Alves Vianna
BV da Influenza - sappg.ufes.br
UNIVERSIDADE FEDERAL DO ESPÍRITO SANTO CENTRO DE CIÊNCIAS DA SAÚDE
PROGRAMA DE PÓS-GRADUAÇÃO EM BIOTECNOLOGIA Lucas Alves Page 1 …
PROGRAMA DE PÓS-GRADUAÇÃO EM BIOTECNOLOGIA Lucas Alves Page 1 …
Magnitude of RSV Fusion Protein-Specific Antibodies in Infants and Corresponding Mothers
S Taleb - 2018 - qspace.qu.edu.qa
INTRODUCTION: Respiratory syncytial virus (RSV) is a threatening agent causing lower
respiratory infections (LRI) among children, where no vaccine is available. RSV expresses …
respiratory infections (LRI) among children, where no vaccine is available. RSV expresses …